The Anti-VEGFR2 Ramuciru Biosimilar (HDBS0058) is a cutting-edge biological product designed for research involving Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), a key player in angiogenesis and tumor growth. This biosimilar antibody, produced using state-of-the-art technology, shows high reactivity with human VEGFR2 samples and is validated for a variety of research applications.VEGFR2 is a critical receptor involved in the formation of new blood vessels, a process known as angiogenesis, which is essential for tumor growth and metastasis in cancer. Inhibiting VEGFR2 activity has been shown to be effective in slowing down tumor progression, making it a promising target for cancer therapy.
The Anti-VEGFR2 Ramuciru Biosimilar (HDBS0058) specifically binds to VEGFR2, allowing for precise detection and analysis in various cell types, making it particularly useful for studies in oncology and angiogenesis research.Understanding the role of VEGFR2 in cancer biology is essential for developing targeted therapies that can effectively block tumor angiogenesis and inhibit cancer progression. The Anti-VEGFR2 Ramuciru Biosimilar (HDBS0058) provides researchers with a valuable tool to further investigate the intricate mechanisms behind VEGFR2 signaling and explore new potential cancer treatment strategies.
Product Name:
Ramucirumab (Anti-VEGFR2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0058
Target:
VEGFR2
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
1121B, IMC-1121B, LY3009806
Description:
Anti-VEGFR2 (ramucirumab biosimilar)mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
